We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Stay Up-to-Date With COVID-19 Drug Development
Article

Stay Up-to-Date With COVID-19 Drug Development

Stay Up-to-Date With COVID-19 Drug Development
Article

Stay Up-to-Date With COVID-19 Drug Development

Read time:
 

Want a FREE PDF version of This Article?

Complete the form below and we will email you a PDF version of "Stay Up-to-Date With COVID-19 Drug Development"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Researchers are working tirelessly to design new drugs and repurpose existing drugs against the novel coronavirus SARS-CoV-2.



Below, you'll find a list of our latest COVID-19 drug-related coverage.

Mini Llama Antibodies Could Help To Fight SARS-CoV-2 Variants

A Chewing Gum Designed To Trap SARS-CoV-2


Predicting Where Coronavirus Binds to Human Proteins 


Plant-Derived Antiviral for COVID-19 Effective Against All Known SARS-CoV-2 Variants

Portal Helps Researchers Screen COVID-19 Drug Candidates

Inhaled COVID-19 Treatment Advances to Phase 3 Study

Drug Reduces SARS-CoV-2 Infection by Up to 70% in Cell-Based Screen


Masitinib Inhibits the Replication of SARS-CoV-2 in Preclinical Models


Small Trials Suggest Ivermectin May Have Sizeable Effects on COVID-19 Mortality

Considerations When Designing COVID-19 Drug Trials

COVID-19: 160 Drugs Identified That Could Be Repurposed

Treating COVID-19: Protein Engineering Approach Could Accelerate Drug Discovery

Compounds Reduce SARS-CoV-2 Replication in Cultured Cells

Certain Gut Bacteria Produce Compounds That Inhibit SARS-CoV-2

Drug Duo Combats SARS-CoV-2 in Cell Culture Models

Several Existing Drugs Possess Antiviral Activity Against SARS-CoV-2

Computational Tool Helps Find Molecules With COVID-19-Fighting Properties

Organ Chip-Based Testing Supports Rapid Drug Repurposing for COVID-19

Hepatitis C Drugs Boost Remdesivir’s Ability To Inhibit SARS-CoV-2 in Cell Culture

"Nanotraps" Designed To Catch and Clear Coronavirus

Experimental Drug MK-4482 for COVID-19 Is Effective in Hamster Study

Fragment Screen Points to New SARS-CoV-2 Inhibitors

A Long-Acting Injectable Therapy To Treat COVID-19

Asthma Drug Reduces Recovery Time in Non-Hospitalized Patients With COVID-19

Nine Potential New COVID-19 Treatments

Phase 1 Study of Novel Oral Antiviral Against SARS-CoV-2 Initiated

“Silencing” nsp14 Protein To Weaken SARS-CoV-2

Unexpected Binding Between SARS-CoV-2 and Antiviral Drug

Anti-SARS-CoV-2 Drug Candidate Enters Phase 1 Trial in the US

Anti-Androgen Drugs May Disarm COVID-19 Spike Protein

Leprosy Drug Exhibits Potent Antiviral Activities Against SARS-CoV-2

A Potential Target for Anti-COVID-19 Therapies

NIH Closes Enrolment for Two Sub-Studies in ACTIV-3 Trial

Team Discovers Drug Candidates That Can Stop SARS-CoV-2 Replication

Four Potential COVID-19 Drugs Enter Phase 2/3 Testing

Budesonide Reduces Need for Hospitalization in COVID-19 Patients, Phase 2 Study Suggests

Anticancer Drug May Speed Up Recovery of Patients With Severe COVID-19

How Vitamins, Steroids and Antiviral Drugs May Affect SARS-CoV-2

Anticancer Drug Demonstrates Activity Against SARS-CoV-2, Including B.1.1.7 Variant in the Lab

Potential Target for Anti-Viral Drugs To Treat COVID-19

Pilot Study Suggests That Ivermectin Can Help To Treat Mild COVID-19

Two Existing Drugs Could Improve Survival in Patients With Severe COVID-19

Treating COVID-19: Baricitinib Plus Remdesivir Shows Promise in Trial

Drug Rapidly Blocks SARS-CoV-2 Transmission in Animal Model

Team Discovers Inhibitors Capable of Blocking the Uptake of SARS-CoV-2

Creating Drugs To Inhibit SARS-CoV-2 Entry and Replication Simultaneously

Aspirin Being Investigated as a Possible Treatment for COVID-19

Study Suggests That Beta-Blockers Could Be Used To Treat COVID-19

Deep Learning Model Helps Drug Developers Target SARS-CoV-2's Main Protease

FDA Approves Remdesivir for COVID-19

Accelerated Screen Identifies 25 Existing Drugs Capable of Disrupting SARS-CoV-2 Cell Entry

Could Amodiaquine Be Effective at Fighting COVID-19?

NIH Study Designed To Identify Promising COVID-19 Treatments for Larger Clinical Trials

ILC Therapeutics Announces COVID-19 Drug Development

Breaking COVID-19’s "Clutch" To Stop Its Spread

Team Identifies Small Molecules That Target SARS-CoV-2 RNA for Destruction

Could a Lipid Be Used To Prevent or Treat SARS-CoV-2 Infection?

REGN-COV2 Antibody Cocktail Reduced Viral Load and Alleviated Symptoms in Non-Hospitalized COVID-19 Patients

Phase 3 Trial Assesses Dual-Antibody Injection's Ability To Prevent SARS-CoV-2 Infection


Team Uncovers New Mechanism of Action Against SARS-CoV-2 by Remdesivir

Drug Shown To Modulate the Inflammatory Response in Severe COVID-19

Tiny Antibody Component Neutralizes SARS-CoV-2 in Animal Models

COVID-19 Phase 3 Trial To Evaluate REGN-COV2 Antibody Cocktail in UK

COVID-19 Drug Discovery and Development – Why Diverse Strategies Are Critical

Synthetic Antiviral Proteins Inhibit SARS-CoV-2 in Lab-Grown Human Cells

The Impact of Genetics on COVID-19 Treatments

Risk of Severe COVID-19 Was Reduced for Patients Taking Blood Pressure Drug

Treating COVID-19 – 21 Existing Drugs Shown To Stop Replication of SARS-CoV-2

Could Steroids Be Used To Combat COVID-19 in Severely Ill Patients?

Ebselen May Be Effective as a Weapon Against Key Coronavirus Enzyme

Machine Learning Approach Identifies Potential Drug Candidates To Treat COVID-19

Study Indicates a Lack of Diversity in COVID-19 Clinical Trials

Existing Alcoholism Drug Potentially Effective Against COVID-19

RLF-100 Trial Shows Rapid Recovery From Respiratory Failure in Critically Ill Patients With COVID-19

Trial Tests Cancer Drug’s Ability To Reduce Respiratory Symptoms of COVID-19

Phase 2 Trial Launched To Investigate LAM-002A as a Treatment for COVID-19

Seaweed Extract Surpasses Remdesivir at Blocking SARS-CoV-2 in Cell Models of COVID-19

Team Identifies 21 Existing Drugs That Stop Replication of SARS-CoV-2

Chloroquine Does Not Inhibit SARS-CoV-2 Infection of Human Lung CellS

Nitric Oxide May Help To Control the Replication and Spread of SARS-CoV-2

Positive Trial Results of SNG001 in Hospitalized COVID-19 Patients

Team Screens Millions of Active Substances Against SARS-CoV-2

Could Heparin Be Used To Stop SARS-CoV-2 From Infecting Human Cells?

Trial Assessing Antiviral Drug DAS181 Against COVID-19 Begins Enrolling Patients

Single Dose of Tocilizumab Linked to 45% Lower Risk of Dying Among COVID-19 Patients on Ventilators

Why Lopinavir and Hydroxychloroquine Are Ineffective in COVID-19 Patients

Additional Data Announced on Use of Remdesivir for Treatment of COVID-19

Compounds Target Key Enzyme Halting SARS-CoV-2 Replication

Hydroxychloroquine and Lopinavir/Ritonavir Treatment Arms for COVID-19 Discontinued

Peptide Combo Could Help Reduce Damage Caused By SARS-CoV-2

Molecules Identified That Shut Down SARS-CoV-2 Polymerase Reaction

Existing Drugs Could Stop SARS-CoV-2 From Hijacking Cells

Clinical Trial Investigates Alpha-1-Antitrypsin for Severe COVID-19 Infection

Lopinavir–Ritonavir: No Clinical Benefit in Hospitalized COVID-19 Patients Studied in RECOVERY Trial

Home-based COVID-19 Trial of Inhaled SNG001 Expanded

Remdesivir Is First COVID-19 Treatment Recommended for EU Authorization

Remdesivir for COVID-19 – Exploring Different Formulations, At-risk Populations and Clinical Progress

UTHealth Evaluates Effectiveness of Canakinumab at Preventing COVID-19-induced Cytokine Release Syndrome

Life-saving Drug for Ventilated COVID-19 Patients Uncovered by UK Experts

Accelerated Efforts To Repurpose Approved Drugs for COVID-19

Combination Drug Treatments for COVID-19 Show Promise in Cell-based Tests

Rheumatoid Arthritis Drug Could Be Repurposed To Treat COVID-19 Patients
Many “First-wave” COVID-19 Clinical Studies Have Significant Design Shortcomings, Says Study

Meet The Authors
Laura Elizabeth Lansdowne
Laura Elizabeth Lansdowne
Managing Editor
Molly Campbell
Molly Campbell
Senior Science Writer
Advertisement